Authors
Masoumeh Alsadat Hosseini, Reihaneh Khademi, Mahshid Shokri, Reza Ghiasi, Ali Doostmohammadi, Mahshid Kharaziha, Sahar Salehi
Published in
Macromolecular bioscience. Volume 26. Issue 6. Pages e00003.
Abstract
Dry eye syndrome (DES) happens as a result of inadequate tear secretion or excessive evaporation, which leads to ocular surface irritation and damage. A major therapeutic challenge is maintaining effective drug concentrations, as topical formulations are rapidly cleared by blinking and tear turnover. To address this limitation, we developed a dual pH- and temperature-responsive composite hydrogel composed of chitosan (Cs)-grafted poly-N-isopropylacrylamide (PNIPAAm)- CPN integrated with alginate-based insulin-imprinted microgels (IMIP). Incorporation of IMIP particles allowed tuning of rheology, swelling behavior, wettability, and biodegradation while preserving proper topical administration. Microgel addition increased viscosity from 3.1 mPa·s (CPN-IMIP10) to 37.3 mPa·s (CPN-IMIP35), and the sol-gel transition between 25 and 37°C enabled flowability at room temperature followed by rapid gelation on the ocular surface. All CPN-IMIP hydrogels exhibited elastic-dominant behavior (G' > G″), confirming formation of a stable, shear-resistant network. Insulin release was tunable: at pH 6.4 and 25°C, diffusion governed delivery (29.8 ± 3.6% at 48 h), whereas at pH 7.4 and 37°C, swelling-controlled release predominated (54.4 ± 4.8%). The composite hydrogels supported human corneal epithelial cell viability and enhanced tear secretion, preserved corneal integrity, and reduced inflammation in a rat DES model. This system provides a minimally invasive, long-acting therapeutic platform for DES.
PMID:
42313981
Bibliographic data and abstract were imported from PubMed on 19 Jun 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 4
- Comments 0